August 22, 2014 6:32 PM ET

Pharmaceuticals

Company Overview of Aventis S.A.

Executive Profile

Benjamin Rovinski Ph.D.

Managing Director, Lumira Capital Corp.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
57--

Background

• Mr. Benjamin Rovinski, also known as Beni, Ph.D., serves as a Managing Director at Lumira Capital Corp. Dr. Rovinski joined Lumira Capital in 2001 with an investment focus on mid- to late-stage private and public life sciences companies. His investment focus is primarily on mid- to late-stage private and public companies involved in drug discovery and development, biological and small molecule therapeutics, drug delivery, specialty pharmaceuticals, and diagnostic devices. ...

Corporate Headquarters

Espace Europeen de l'Entreprise
Strasbourg, Alsace 67917

France

Phone: 33 3 88 99 11 00
Fax: 33 1 47 68 19 11

Board Members Memberships

Former Director
2006-Present
Director
2013-Present
Independent Director and Member of Compensation Committee

Education

BS
Rice University
PhD
McGill University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aventis S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.